Total Payments
$9,477
2023 Payments
$724.29
Companies
48
Transactions
581
Medicare Patients
2,248
Medicare Billing
$158,465
Payment Breakdown by Category
Food & Beverage$9,295 (98.1%)
Education$181.73 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,295 | 559 | 98.1% |
| Education | $181.73 | 22 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,511 | 73 | $0 (2023) |
| Lilly USA, LLC | $937.13 | 65 | $0 (2023) |
| ABBVIE INC. | $761.44 | 47 | $0 (2023) |
| PFIZER INC. | $736.70 | 54 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $653.01 | 48 | $0 (2022) |
| Novo Nordisk Inc | $606.49 | 41 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $424.81 | 23 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $354.43 | 19 | $0 (2023) |
| Allergan, Inc. | $351.97 | 25 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $343.48 | 29 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $724.29 | 41 | E.R. Squibb & Sons, L.L.C. ($130.55) |
| 2022 | $1,884 | 105 | AstraZeneca Pharmaceuticals LP ($299.05) |
| 2021 | $1,851 | 111 | AbbVie Inc. ($417.81) |
| 2020 | $1,756 | 110 | AstraZeneca Pharmaceuticals LP ($419.72) |
| 2019 | $1,096 | 69 | AstraZeneca Pharmaceuticals LP ($293.23) |
| 2018 | $883.36 | 68 | PFIZER INC. ($161.94) |
| 2017 | $1,283 | 77 | PFIZER INC. ($211.19) |
All Payment Transactions
581 individual payment records from CMS Open Payments — Page 2 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Cardio-renal | ||||||
| 02/21/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Diabetes | ||||||
| 02/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 02/08/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/03/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $30.56 | General |
| Category: Cardiovascular | ||||||
| 02/03/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 02/03/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 02/02/2023 | MEDLINE INDUSTRIES LP | — | Food and Beverage | In-kind items and services | $17.96 | General |
| 02/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Diabetes | ||||||
| 01/31/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Cardio-renal | ||||||
| 01/30/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | PFIZER INC. | PREVNAR 13 (Biological), TRUMENBA, PREVNAR 20 | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: VACCINES | ||||||
| 01/19/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Oncology | ||||||
| 01/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Cardiovascular | ||||||
| 12/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | In-kind items and services | $9.09 | General |
| Category: Cardiovascular | ||||||
| 12/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.03 | General |
| Category: Cardiovascular | ||||||
| 12/22/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.33 | General |
| Category: Cardiovascular | ||||||
| 12/19/2022 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/15/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/14/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | Organon LLC | — | Food and Beverage | In-kind items and services | $16.55 | General |
| 12/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 177 | 234 | $43,098 | $8,956 |
| 2022 | 8 | 481 | 702 | $142,132 | $38,525 |
| 2021 | 13 | 751 | 1,043 | $193,528 | $54,872 |
| 2020 | 19 | 839 | 1,279 | $202,617 | $56,112 |
Total Patients
2,248
Total Services
3,258
Medicare Billing
$158,465
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 135 | $22,070 | $4,463 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 52 | $16,640 | $2,870 | 17.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $3,863 | $1,353 | 35.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 33 | 35 | $525.00 | $270.57 | 51.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 161 | 292 | $56,432 | $16,224 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 174 | $55,680 | $12,889 | 23.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 64 | 64 | $20,670 | $8,050 | 38.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,324 | $802.57 | 15.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 102 | $1,530 | $298.05 | 19.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 18 | $1,170 | $172.36 | 14.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 21 | $546.00 | $46.42 | 8.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 20 | 20 | $780.00 | $42.36 | 5.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 178 | 329 | $72,380 | $19,321 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 220 | $70,400 | $18,934 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 74 | 74 | $23,828 | $9,490 | 39.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 14 | $6,034 | $1,967 | 32.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 34 | 34 | $1,912 | $1,795 | 93.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $5,372 | $1,044 | 19.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 40 | 40 | $1,840 | $654.72 | 35.6% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 44 | 60 | $3,900 | $582.60 | 14.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 36 | $1,764 | $340.37 | 19.3% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 93 | 95 | $3,705 | $225.54 | 6.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 67 | 72 | $1,080 | $216.00 | 20.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $299.00 | $213.48 | 71.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 30 | 39 | $1,014 | $87.75 | 8.7% |
About Dr. Lance Large, MD
Dr. Lance Large, MD is a Family Medicine healthcare provider based in Stayton, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750362554.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lance Large, MD has received a total of $9,477 in payments from pharmaceutical and medical device companies, with $724.29 received in 2023. These payments were reported across 581 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($9,295).
As a Medicare-enrolled provider, Large has provided services to 2,248 Medicare beneficiaries, totaling 3,258 services with total Medicare billing of $158,465. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Stayton, OR
- Active Since 11/08/2005
- Last Updated 03/04/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1750362554
Products in Payments
- FARXIGA (Drug) $1,214
- VRAYLAR (Drug) $402.87
- TRULICITY (Drug) $399.03
- XARELTO (Drug) $387.10
- UBRELVY (Drug) $385.48
- ENTRESTO (Drug) $315.31
- EMGALITY (Drug) $304.41
- ELIQUIS (Drug) $302.01
- Ozempic (Drug) $294.10
- INVOKANA (Drug) $248.34
- CHANTIX (Drug) $234.13
- SOLIQUA 100/33 (Biological) $224.98
- EVENITY (Biological) $202.74
- Vascepa (Drug) $196.57
- SYMBICORT (Drug) $184.34
- QULIPTA (Drug) $165.54
- MOUNJARO (Drug) $159.47
- NURTEC ODT (Drug) $155.97
- Kerendia (Drug) $140.74
- Tresiba (Drug) $131.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Stayton
Dr. Richard Boughn, Md, MD
Family Medicine — Payments: $1,074
Family Medicine $1,074
Dr. Claire King, Md, MD
Family Medicine — Payments: $740.70
Family Medicine $740.70
Dr. Paul Neumann, M.d, M.D
Family Medicine — Payments: $77.68
Family Medicine $77.68
Lawrence Barnes, Md, MD
Family Medicine — Payments: $29.00
Family Medicine $29.00
David Foster, Md, MD
Family Medicine — Payments: $23.05
Family Medicine $23.05
Dr. Dean Yeager, Md, MD
Family Medicine
Family Medicine